Pharma & Healthcare
Global Platinum-based Anticancer Drugs Market Research Report 2025
- Jul 28, 25
- ID: 409410
- Pages: 106
- Figures: 107
- Views: 8
The global market for Platinum-based Anticancer Drugs was valued at US$ 1609 million in the year 2024 and is projected to reach a revised size of US$ 1857 million by 2031, growing at a CAGR of 2.1% during the forecast period.
Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Platinum-based Anticancer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Platinum-based Anticancer Drugs.
The Platinum-based Anticancer Drugs market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Platinum-based Anticancer Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Platinum-based Anticancer Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Sanofi-Aventis
Yakult honsha
Dr Reddy's laboratories
Sun Pharmaceutical
Teva
Fresenius Kabi
Hospira(Pfizer)
Mylan
Taj Pharmaceuticals
Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Jiangsu Aosaikang Pharmaceutical
Qilu Pharmaceutical
Hisun Pharmaceutical
Luoxin
Lingnan Pharmacy
Hansoh Pharma
Segment by Type
Cisplatin
Carboplatin
Oxaliplatin
Nedaplatin
Others
Segment by Application
Testicular Cancer
Osteosarcoma
Breast Cancer
Esophageal Cancer
NSCLC
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Platinum-based Anticancer Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Platinum-based Anticancer Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Platinum-based Anticancer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Platinum-based Anticancer Drugs.
The Platinum-based Anticancer Drugs market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Platinum-based Anticancer Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Platinum-based Anticancer Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Sanofi-Aventis
Yakult honsha
Dr Reddy's laboratories
Sun Pharmaceutical
Teva
Fresenius Kabi
Hospira(Pfizer)
Mylan
Taj Pharmaceuticals
Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Jiangsu Aosaikang Pharmaceutical
Qilu Pharmaceutical
Hisun Pharmaceutical
Luoxin
Lingnan Pharmacy
Hansoh Pharma
Segment by Type
Cisplatin
Carboplatin
Oxaliplatin
Nedaplatin
Others
Segment by Application
Testicular Cancer
Osteosarcoma
Breast Cancer
Esophageal Cancer
NSCLC
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Platinum-based Anticancer Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Platinum-based Anticancer Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Platinum-based Anticancer Drugs Market Overview
1.1 Product Definition
1.2 Platinum-based Anticancer Drugs by Type
1.2.1 Global Platinum-based Anticancer Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Cisplatin
1.2.3 Carboplatin
1.2.4 Oxaliplatin
1.2.5 Nedaplatin
1.2.6 Others
1.3 Platinum-based Anticancer Drugs by Application
1.3.1 Global Platinum-based Anticancer Drugs Market Value by Application (2024 VS 2031)
1.3.2 Testicular Cancer
1.3.3 Osteosarcoma
1.3.4 Breast Cancer
1.3.5 Esophageal Cancer
1.3.6 NSCLC
1.3.7 Other
1.4 Global Platinum-based Anticancer Drugs Market Size Estimates and Forecasts
1.4.1 Global Platinum-based Anticancer Drugs Revenue 2020-2031
1.4.2 Global Platinum-based Anticancer Drugs Sales 2020-2031
1.4.3 Global Platinum-based Anticancer Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Platinum-based Anticancer Drugs Market Competition by Manufacturers
2.1 Global Platinum-based Anticancer Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Platinum-based Anticancer Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Platinum-based Anticancer Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Platinum-based Anticancer Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Platinum-based Anticancer Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Platinum-based Anticancer Drugs, Product Type & Application
2.7 Global Key Manufacturers of Platinum-based Anticancer Drugs, Date of Enter into This Industry
2.8 Global Platinum-based Anticancer Drugs Market Competitive Situation and Trends
2.8.1 Global Platinum-based Anticancer Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Platinum-based Anticancer Drugs Players Market Share by Revenue
2.8.3 Global Platinum-based Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Platinum-based Anticancer Drugs Market Scenario by Region
3.1 Global Platinum-based Anticancer Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Platinum-based Anticancer Drugs Sales by Region: 2020-2031
3.2.1 Global Platinum-based Anticancer Drugs Sales by Region: 2020-2025
3.2.2 Global Platinum-based Anticancer Drugs Sales by Region: 2026-2031
3.3 Global Platinum-based Anticancer Drugs Revenue by Region: 2020-2031
3.3.1 Global Platinum-based Anticancer Drugs Revenue by Region: 2020-2025
3.3.2 Global Platinum-based Anticancer Drugs Revenue by Region: 2026-2031
3.4 North America Platinum-based Anticancer Drugs Market Facts & Figures by Country
3.4.1 North America Platinum-based Anticancer Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Platinum-based Anticancer Drugs Sales by Country (2020-2031)
3.4.3 North America Platinum-based Anticancer Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Platinum-based Anticancer Drugs Market Facts & Figures by Country
3.5.1 Europe Platinum-based Anticancer Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Platinum-based Anticancer Drugs Sales by Country (2020-2031)
3.5.3 Europe Platinum-based Anticancer Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Platinum-based Anticancer Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Platinum-based Anticancer Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Platinum-based Anticancer Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Platinum-based Anticancer Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Platinum-based Anticancer Drugs Market Facts & Figures by Country
3.7.1 Latin America Platinum-based Anticancer Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Platinum-based Anticancer Drugs Sales by Country (2020-2031)
3.7.3 Latin America Platinum-based Anticancer Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Platinum-based Anticancer Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Platinum-based Anticancer Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Platinum-based Anticancer Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Platinum-based Anticancer Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Platinum-based Anticancer Drugs Sales by Type (2020-2031)
4.1.1 Global Platinum-based Anticancer Drugs Sales by Type (2020-2025)
4.1.2 Global Platinum-based Anticancer Drugs Sales by Type (2026-2031)
4.1.3 Global Platinum-based Anticancer Drugs Sales Market Share by Type (2020-2031)
4.2 Global Platinum-based Anticancer Drugs Revenue by Type (2020-2031)
4.2.1 Global Platinum-based Anticancer Drugs Revenue by Type (2020-2025)
4.2.2 Global Platinum-based Anticancer Drugs Revenue by Type (2026-2031)
4.2.3 Global Platinum-based Anticancer Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Platinum-based Anticancer Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Platinum-based Anticancer Drugs Sales by Application (2020-2031)
5.1.1 Global Platinum-based Anticancer Drugs Sales by Application (2020-2025)
5.1.2 Global Platinum-based Anticancer Drugs Sales by Application (2026-2031)
5.1.3 Global Platinum-based Anticancer Drugs Sales Market Share by Application (2020-2031)
5.2 Global Platinum-based Anticancer Drugs Revenue by Application (2020-2031)
5.2.1 Global Platinum-based Anticancer Drugs Revenue by Application (2020-2025)
5.2.2 Global Platinum-based Anticancer Drugs Revenue by Application (2026-2031)
5.2.3 Global Platinum-based Anticancer Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Platinum-based Anticancer Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi-Aventis
6.1.1 Sanofi-Aventis Company Information
6.1.2 Sanofi-Aventis Description and Business Overview
6.1.3 Sanofi-Aventis Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi-Aventis Platinum-based Anticancer Drugs Product Portfolio
6.1.5 Sanofi-Aventis Recent Developments/Updates
6.2 Yakult honsha
6.2.1 Yakult honsha Company Information
6.2.2 Yakult honsha Description and Business Overview
6.2.3 Yakult honsha Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Yakult honsha Platinum-based Anticancer Drugs Product Portfolio
6.2.5 Yakult honsha Recent Developments/Updates
6.3 Dr Reddy's laboratories
6.3.1 Dr Reddy's laboratories Company Information
6.3.2 Dr Reddy's laboratories Description and Business Overview
6.3.3 Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Dr Reddy's laboratories Platinum-based Anticancer Drugs Product Portfolio
6.3.5 Dr Reddy's laboratories Recent Developments/Updates
6.4 Sun Pharmaceutical
6.4.1 Sun Pharmaceutical Company Information
6.4.2 Sun Pharmaceutical Description and Business Overview
6.4.3 Sun Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sun Pharmaceutical Platinum-based Anticancer Drugs Product Portfolio
6.4.5 Sun Pharmaceutical Recent Developments/Updates
6.5 Teva
6.5.1 Teva Company Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teva Platinum-based Anticancer Drugs Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 Fresenius Kabi
6.6.1 Fresenius Kabi Company Information
6.6.2 Fresenius Kabi Description and Business Overview
6.6.3 Fresenius Kabi Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Fresenius Kabi Platinum-based Anticancer Drugs Product Portfolio
6.6.5 Fresenius Kabi Recent Developments/Updates
6.7 Hospira(Pfizer)
6.7.1 Hospira(Pfizer) Company Information
6.7.2 Hospira(Pfizer) Description and Business Overview
6.7.3 Hospira(Pfizer) Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hospira(Pfizer) Platinum-based Anticancer Drugs Product Portfolio
6.7.5 Hospira(Pfizer) Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Company Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Mylan Platinum-based Anticancer Drugs Product Portfolio
6.8.5 Mylan Recent Developments/Updates
6.9 Taj Pharmaceuticals
6.9.1 Taj Pharmaceuticals Company Information
6.9.2 Taj Pharmaceuticals Description and Business Overview
6.9.3 Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Taj Pharmaceuticals Platinum-based Anticancer Drugs Product Portfolio
6.9.5 Taj Pharmaceuticals Recent Developments/Updates
6.10 Jiangsu Hengrui Medicine
6.10.1 Jiangsu Hengrui Medicine Company Information
6.10.2 Jiangsu Hengrui Medicine Description and Business Overview
6.10.3 Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Product Portfolio
6.10.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.11 Nanjing Pharmaceutical Factory
6.11.1 Nanjing Pharmaceutical Factory Company Information
6.11.2 Nanjing Pharmaceutical Factory Description and Business Overview
6.11.3 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Product Portfolio
6.11.5 Nanjing Pharmaceutical Factory Recent Developments/Updates
6.12 Jiangsu Aosaikang Pharmaceutical
6.12.1 Jiangsu Aosaikang Pharmaceutical Company Information
6.12.2 Jiangsu Aosaikang Pharmaceutical Description and Business Overview
6.12.3 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Product Portfolio
6.12.5 Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
6.13 Qilu Pharmaceutical
6.13.1 Qilu Pharmaceutical Company Information
6.13.2 Qilu Pharmaceutical Description and Business Overview
6.13.3 Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Qilu Pharmaceutical Platinum-based Anticancer Drugs Product Portfolio
6.13.5 Qilu Pharmaceutical Recent Developments/Updates
6.14 Hisun Pharmaceutical
6.14.1 Hisun Pharmaceutical Company Information
6.14.2 Hisun Pharmaceutical Description and Business Overview
6.14.3 Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Hisun Pharmaceutical Platinum-based Anticancer Drugs Product Portfolio
6.14.5 Hisun Pharmaceutical Recent Developments/Updates
6.15 Luoxin
6.15.1 Luoxin Company Information
6.15.2 Luoxin Description and Business Overview
6.15.3 Luoxin Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Luoxin Platinum-based Anticancer Drugs Product Portfolio
6.15.5 Luoxin Recent Developments/Updates
6.16 Lingnan Pharmacy
6.16.1 Lingnan Pharmacy Company Information
6.16.2 Lingnan Pharmacy Description and Business Overview
6.16.3 Lingnan Pharmacy Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Lingnan Pharmacy Platinum-based Anticancer Drugs Product Portfolio
6.16.5 Lingnan Pharmacy Recent Developments/Updates
6.17 Hansoh Pharma
6.17.1 Hansoh Pharma Company Information
6.17.2 Hansoh Pharma Description and Business Overview
6.17.3 Hansoh Pharma Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Hansoh Pharma Platinum-based Anticancer Drugs Product Portfolio
6.17.5 Hansoh Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Platinum-based Anticancer Drugs Industry Chain Analysis
7.2 Platinum-based Anticancer Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Platinum-based Anticancer Drugs Production Mode & Process Analysis
7.4 Platinum-based Anticancer Drugs Sales and Marketing
7.4.1 Platinum-based Anticancer Drugs Sales Channels
7.4.2 Platinum-based Anticancer Drugs Distributors
7.5 Platinum-based Anticancer Drugs Customer Analysis
8 Platinum-based Anticancer Drugs Market Dynamics
8.1 Platinum-based Anticancer Drugs Industry Trends
8.2 Platinum-based Anticancer Drugs Market Drivers
8.3 Platinum-based Anticancer Drugs Market Challenges
8.4 Platinum-based Anticancer Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Platinum-based Anticancer Drugs by Type
1.2.1 Global Platinum-based Anticancer Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Cisplatin
1.2.3 Carboplatin
1.2.4 Oxaliplatin
1.2.5 Nedaplatin
1.2.6 Others
1.3 Platinum-based Anticancer Drugs by Application
1.3.1 Global Platinum-based Anticancer Drugs Market Value by Application (2024 VS 2031)
1.3.2 Testicular Cancer
1.3.3 Osteosarcoma
1.3.4 Breast Cancer
1.3.5 Esophageal Cancer
1.3.6 NSCLC
1.3.7 Other
1.4 Global Platinum-based Anticancer Drugs Market Size Estimates and Forecasts
1.4.1 Global Platinum-based Anticancer Drugs Revenue 2020-2031
1.4.2 Global Platinum-based Anticancer Drugs Sales 2020-2031
1.4.3 Global Platinum-based Anticancer Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Platinum-based Anticancer Drugs Market Competition by Manufacturers
2.1 Global Platinum-based Anticancer Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Platinum-based Anticancer Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Platinum-based Anticancer Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Platinum-based Anticancer Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Platinum-based Anticancer Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Platinum-based Anticancer Drugs, Product Type & Application
2.7 Global Key Manufacturers of Platinum-based Anticancer Drugs, Date of Enter into This Industry
2.8 Global Platinum-based Anticancer Drugs Market Competitive Situation and Trends
2.8.1 Global Platinum-based Anticancer Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Platinum-based Anticancer Drugs Players Market Share by Revenue
2.8.3 Global Platinum-based Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Platinum-based Anticancer Drugs Market Scenario by Region
3.1 Global Platinum-based Anticancer Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Platinum-based Anticancer Drugs Sales by Region: 2020-2031
3.2.1 Global Platinum-based Anticancer Drugs Sales by Region: 2020-2025
3.2.2 Global Platinum-based Anticancer Drugs Sales by Region: 2026-2031
3.3 Global Platinum-based Anticancer Drugs Revenue by Region: 2020-2031
3.3.1 Global Platinum-based Anticancer Drugs Revenue by Region: 2020-2025
3.3.2 Global Platinum-based Anticancer Drugs Revenue by Region: 2026-2031
3.4 North America Platinum-based Anticancer Drugs Market Facts & Figures by Country
3.4.1 North America Platinum-based Anticancer Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Platinum-based Anticancer Drugs Sales by Country (2020-2031)
3.4.3 North America Platinum-based Anticancer Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Platinum-based Anticancer Drugs Market Facts & Figures by Country
3.5.1 Europe Platinum-based Anticancer Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Platinum-based Anticancer Drugs Sales by Country (2020-2031)
3.5.3 Europe Platinum-based Anticancer Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Platinum-based Anticancer Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Platinum-based Anticancer Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Platinum-based Anticancer Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Platinum-based Anticancer Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Platinum-based Anticancer Drugs Market Facts & Figures by Country
3.7.1 Latin America Platinum-based Anticancer Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Platinum-based Anticancer Drugs Sales by Country (2020-2031)
3.7.3 Latin America Platinum-based Anticancer Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Platinum-based Anticancer Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Platinum-based Anticancer Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Platinum-based Anticancer Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Platinum-based Anticancer Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Platinum-based Anticancer Drugs Sales by Type (2020-2031)
4.1.1 Global Platinum-based Anticancer Drugs Sales by Type (2020-2025)
4.1.2 Global Platinum-based Anticancer Drugs Sales by Type (2026-2031)
4.1.3 Global Platinum-based Anticancer Drugs Sales Market Share by Type (2020-2031)
4.2 Global Platinum-based Anticancer Drugs Revenue by Type (2020-2031)
4.2.1 Global Platinum-based Anticancer Drugs Revenue by Type (2020-2025)
4.2.2 Global Platinum-based Anticancer Drugs Revenue by Type (2026-2031)
4.2.3 Global Platinum-based Anticancer Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Platinum-based Anticancer Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Platinum-based Anticancer Drugs Sales by Application (2020-2031)
5.1.1 Global Platinum-based Anticancer Drugs Sales by Application (2020-2025)
5.1.2 Global Platinum-based Anticancer Drugs Sales by Application (2026-2031)
5.1.3 Global Platinum-based Anticancer Drugs Sales Market Share by Application (2020-2031)
5.2 Global Platinum-based Anticancer Drugs Revenue by Application (2020-2031)
5.2.1 Global Platinum-based Anticancer Drugs Revenue by Application (2020-2025)
5.2.2 Global Platinum-based Anticancer Drugs Revenue by Application (2026-2031)
5.2.3 Global Platinum-based Anticancer Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Platinum-based Anticancer Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi-Aventis
6.1.1 Sanofi-Aventis Company Information
6.1.2 Sanofi-Aventis Description and Business Overview
6.1.3 Sanofi-Aventis Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi-Aventis Platinum-based Anticancer Drugs Product Portfolio
6.1.5 Sanofi-Aventis Recent Developments/Updates
6.2 Yakult honsha
6.2.1 Yakult honsha Company Information
6.2.2 Yakult honsha Description and Business Overview
6.2.3 Yakult honsha Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Yakult honsha Platinum-based Anticancer Drugs Product Portfolio
6.2.5 Yakult honsha Recent Developments/Updates
6.3 Dr Reddy's laboratories
6.3.1 Dr Reddy's laboratories Company Information
6.3.2 Dr Reddy's laboratories Description and Business Overview
6.3.3 Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Dr Reddy's laboratories Platinum-based Anticancer Drugs Product Portfolio
6.3.5 Dr Reddy's laboratories Recent Developments/Updates
6.4 Sun Pharmaceutical
6.4.1 Sun Pharmaceutical Company Information
6.4.2 Sun Pharmaceutical Description and Business Overview
6.4.3 Sun Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sun Pharmaceutical Platinum-based Anticancer Drugs Product Portfolio
6.4.5 Sun Pharmaceutical Recent Developments/Updates
6.5 Teva
6.5.1 Teva Company Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teva Platinum-based Anticancer Drugs Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 Fresenius Kabi
6.6.1 Fresenius Kabi Company Information
6.6.2 Fresenius Kabi Description and Business Overview
6.6.3 Fresenius Kabi Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Fresenius Kabi Platinum-based Anticancer Drugs Product Portfolio
6.6.5 Fresenius Kabi Recent Developments/Updates
6.7 Hospira(Pfizer)
6.7.1 Hospira(Pfizer) Company Information
6.7.2 Hospira(Pfizer) Description and Business Overview
6.7.3 Hospira(Pfizer) Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hospira(Pfizer) Platinum-based Anticancer Drugs Product Portfolio
6.7.5 Hospira(Pfizer) Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Company Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Mylan Platinum-based Anticancer Drugs Product Portfolio
6.8.5 Mylan Recent Developments/Updates
6.9 Taj Pharmaceuticals
6.9.1 Taj Pharmaceuticals Company Information
6.9.2 Taj Pharmaceuticals Description and Business Overview
6.9.3 Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Taj Pharmaceuticals Platinum-based Anticancer Drugs Product Portfolio
6.9.5 Taj Pharmaceuticals Recent Developments/Updates
6.10 Jiangsu Hengrui Medicine
6.10.1 Jiangsu Hengrui Medicine Company Information
6.10.2 Jiangsu Hengrui Medicine Description and Business Overview
6.10.3 Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Product Portfolio
6.10.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.11 Nanjing Pharmaceutical Factory
6.11.1 Nanjing Pharmaceutical Factory Company Information
6.11.2 Nanjing Pharmaceutical Factory Description and Business Overview
6.11.3 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Product Portfolio
6.11.5 Nanjing Pharmaceutical Factory Recent Developments/Updates
6.12 Jiangsu Aosaikang Pharmaceutical
6.12.1 Jiangsu Aosaikang Pharmaceutical Company Information
6.12.2 Jiangsu Aosaikang Pharmaceutical Description and Business Overview
6.12.3 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Product Portfolio
6.12.5 Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
6.13 Qilu Pharmaceutical
6.13.1 Qilu Pharmaceutical Company Information
6.13.2 Qilu Pharmaceutical Description and Business Overview
6.13.3 Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Qilu Pharmaceutical Platinum-based Anticancer Drugs Product Portfolio
6.13.5 Qilu Pharmaceutical Recent Developments/Updates
6.14 Hisun Pharmaceutical
6.14.1 Hisun Pharmaceutical Company Information
6.14.2 Hisun Pharmaceutical Description and Business Overview
6.14.3 Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Hisun Pharmaceutical Platinum-based Anticancer Drugs Product Portfolio
6.14.5 Hisun Pharmaceutical Recent Developments/Updates
6.15 Luoxin
6.15.1 Luoxin Company Information
6.15.2 Luoxin Description and Business Overview
6.15.3 Luoxin Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Luoxin Platinum-based Anticancer Drugs Product Portfolio
6.15.5 Luoxin Recent Developments/Updates
6.16 Lingnan Pharmacy
6.16.1 Lingnan Pharmacy Company Information
6.16.2 Lingnan Pharmacy Description and Business Overview
6.16.3 Lingnan Pharmacy Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Lingnan Pharmacy Platinum-based Anticancer Drugs Product Portfolio
6.16.5 Lingnan Pharmacy Recent Developments/Updates
6.17 Hansoh Pharma
6.17.1 Hansoh Pharma Company Information
6.17.2 Hansoh Pharma Description and Business Overview
6.17.3 Hansoh Pharma Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Hansoh Pharma Platinum-based Anticancer Drugs Product Portfolio
6.17.5 Hansoh Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Platinum-based Anticancer Drugs Industry Chain Analysis
7.2 Platinum-based Anticancer Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Platinum-based Anticancer Drugs Production Mode & Process Analysis
7.4 Platinum-based Anticancer Drugs Sales and Marketing
7.4.1 Platinum-based Anticancer Drugs Sales Channels
7.4.2 Platinum-based Anticancer Drugs Distributors
7.5 Platinum-based Anticancer Drugs Customer Analysis
8 Platinum-based Anticancer Drugs Market Dynamics
8.1 Platinum-based Anticancer Drugs Industry Trends
8.2 Platinum-based Anticancer Drugs Market Drivers
8.3 Platinum-based Anticancer Drugs Market Challenges
8.4 Platinum-based Anticancer Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Platinum-based Anticancer Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Platinum-based Anticancer Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Platinum-based Anticancer Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Platinum-based Anticancer Drugs Sales (MT) of Key Manufacturers (2020-2025)
Table 5. Global Platinum-based Anticancer Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Platinum-based Anticancer Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Platinum-based Anticancer Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Platinum-based Anticancer Drugs Average Price (US$/MT) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Platinum-based Anticancer Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Platinum-based Anticancer Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Platinum-based Anticancer Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Platinum-based Anticancer Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Platinum-based Anticancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Platinum-based Anticancer Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Platinum-based Anticancer Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Platinum-based Anticancer Drugs Sales by Region (2020-2025) & (MT)
Table 18. Global Platinum-based Anticancer Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Platinum-based Anticancer Drugs Sales by Region (2026-2031) & (MT)
Table 20. Global Platinum-based Anticancer Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Platinum-based Anticancer Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Platinum-based Anticancer Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Platinum-based Anticancer Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Platinum-based Anticancer Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Platinum-based Anticancer Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Platinum-based Anticancer Drugs Sales by Country (2020-2025) & (MT)
Table 27. North America Platinum-based Anticancer Drugs Sales by Country (2026-2031) & (MT)
Table 28. North America Platinum-based Anticancer Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Platinum-based Anticancer Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Platinum-based Anticancer Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Platinum-based Anticancer Drugs Sales by Country (2020-2025) & (MT)
Table 32. Europe Platinum-based Anticancer Drugs Sales by Country (2026-2031) & (MT)
Table 33. Europe Platinum-based Anticancer Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Platinum-based Anticancer Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Platinum-based Anticancer Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Platinum-based Anticancer Drugs Sales by Region (2020-2025) & (MT)
Table 37. Asia Pacific Platinum-based Anticancer Drugs Sales by Region (2026-2031) & (MT)
Table 38. Asia Pacific Platinum-based Anticancer Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Platinum-based Anticancer Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Platinum-based Anticancer Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Platinum-based Anticancer Drugs Sales by Country (2020-2025) & (MT)
Table 42. Latin America Platinum-based Anticancer Drugs Sales by Country (2026-2031) & (MT)
Table 43. Latin America Platinum-based Anticancer Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Platinum-based Anticancer Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Platinum-based Anticancer Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Platinum-based Anticancer Drugs Sales by Country (2020-2025) & (MT)
Table 47. Middle East and Africa Platinum-based Anticancer Drugs Sales by Country (2026-2031) & (MT)
Table 48. Middle East and Africa Platinum-based Anticancer Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Platinum-based Anticancer Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Platinum-based Anticancer Drugs Sales (MT) by Type (2020-2025)
Table 51. Global Platinum-based Anticancer Drugs Sales (MT) by Type (2026-2031)
Table 52. Global Platinum-based Anticancer Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Platinum-based Anticancer Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Platinum-based Anticancer Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Platinum-based Anticancer Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Platinum-based Anticancer Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Platinum-based Anticancer Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Platinum-based Anticancer Drugs Price (US$/MT) by Type (2020-2025)
Table 59. Global Platinum-based Anticancer Drugs Price (US$/MT) by Type (2026-2031)
Table 60. Global Platinum-based Anticancer Drugs Sales (MT) by Application (2020-2025)
Table 61. Global Platinum-based Anticancer Drugs Sales (MT) by Application (2026-2031)
Table 62. Global Platinum-based Anticancer Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Platinum-based Anticancer Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Platinum-based Anticancer Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Platinum-based Anticancer Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Platinum-based Anticancer Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Platinum-based Anticancer Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Platinum-based Anticancer Drugs Price (US$/MT) by Application (2020-2025)
Table 69. Global Platinum-based Anticancer Drugs Price (US$/MT) by Application (2026-2031)
Table 70. Sanofi-Aventis Company Information
Table 71. Sanofi-Aventis Description and Business Overview
Table 72. Sanofi-Aventis Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 73. Sanofi-Aventis Platinum-based Anticancer Drugs Product
Table 74. Sanofi-Aventis Recent Developments/Updates
Table 75. Yakult honsha Company Information
Table 76. Yakult honsha Description and Business Overview
Table 77. Yakult honsha Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 78. Yakult honsha Platinum-based Anticancer Drugs Product
Table 79. Yakult honsha Recent Developments/Updates
Table 80. Dr Reddy's laboratories Company Information
Table 81. Dr Reddy's laboratories Description and Business Overview
Table 82. Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 83. Dr Reddy's laboratories Platinum-based Anticancer Drugs Product
Table 84. Dr Reddy's laboratories Recent Developments/Updates
Table 85. Sun Pharmaceutical Company Information
Table 86. Sun Pharmaceutical Description and Business Overview
Table 87. Sun Pharmaceutical Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 88. Sun Pharmaceutical Platinum-based Anticancer Drugs Product
Table 89. Sun Pharmaceutical Recent Developments/Updates
Table 90. Teva Company Information
Table 91. Teva Description and Business Overview
Table 92. Teva Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 93. Teva Platinum-based Anticancer Drugs Product
Table 94. Teva Recent Developments/Updates
Table 95. Fresenius Kabi Company Information
Table 96. Fresenius Kabi Description and Business Overview
Table 97. Fresenius Kabi Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 98. Fresenius Kabi Platinum-based Anticancer Drugs Product
Table 99. Fresenius Kabi Recent Developments/Updates
Table 100. Hospira(Pfizer) Company Information
Table 101. Hospira(Pfizer) Description and Business Overview
Table 102. Hospira(Pfizer) Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 103. Hospira(Pfizer) Platinum-based Anticancer Drugs Product
Table 104. Hospira(Pfizer) Recent Developments/Updates
Table 105. Mylan Company Information
Table 106. Mylan Description and Business Overview
Table 107. Mylan Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 108. Mylan Platinum-based Anticancer Drugs Product
Table 109. Mylan Recent Developments/Updates
Table 110. Taj Pharmaceuticals Company Information
Table 111. Taj Pharmaceuticals Description and Business Overview
Table 112. Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 113. Taj Pharmaceuticals Platinum-based Anticancer Drugs Product
Table 114. Taj Pharmaceuticals Recent Developments/Updates
Table 115. Jiangsu Hengrui Medicine Company Information
Table 116. Jiangsu Hengrui Medicine Description and Business Overview
Table 117. Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 118. Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Product
Table 119. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 120. Nanjing Pharmaceutical Factory Company Information
Table 121. Nanjing Pharmaceutical Factory Description and Business Overview
Table 122. Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 123. Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Product
Table 124. Nanjing Pharmaceutical Factory Recent Developments/Updates
Table 125. Jiangsu Aosaikang Pharmaceutical Company Information
Table 126. Jiangsu Aosaikang Pharmaceutical Description and Business Overview
Table 127. Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 128. Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Product
Table 129. Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
Table 130. Qilu Pharmaceutical Company Information
Table 131. Qilu Pharmaceutical Description and Business Overview
Table 132. Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 133. Qilu Pharmaceutical Platinum-based Anticancer Drugs Product
Table 134. Qilu Pharmaceutical Recent Developments/Updates
Table 135. Hisun Pharmaceutical Company Information
Table 136. Hisun Pharmaceutical Description and Business Overview
Table 137. Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 138. Hisun Pharmaceutical Platinum-based Anticancer Drugs Product
Table 139. Hisun Pharmaceutical Recent Developments/Updates
Table 140. Luoxin Company Information
Table 141. Luoxin Description and Business Overview
Table 142. Luoxin Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 143. Luoxin Platinum-based Anticancer Drugs Product
Table 144. Luoxin Recent Developments/Updates
Table 145. Lingnan Pharmacy Company Information
Table 146. Lingnan Pharmacy Description and Business Overview
Table 147. Lingnan Pharmacy Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 148. Lingnan Pharmacy Platinum-based Anticancer Drugs Product
Table 149. Lingnan Pharmacy Recent Developments/Updates
Table 150. Hansoh Pharma Company Information
Table 151. Hansoh Pharma Description and Business Overview
Table 152. Hansoh Pharma Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 153. Hansoh Pharma Platinum-based Anticancer Drugs Product
Table 154. Hansoh Pharma Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Platinum-based Anticancer Drugs Distributors List
Table 158. Platinum-based Anticancer Drugs Customers List
Table 159. Platinum-based Anticancer Drugs Market Trends
Table 160. Platinum-based Anticancer Drugs Market Drivers
Table 161. Platinum-based Anticancer Drugs Market Challenges
Table 162. Platinum-based Anticancer Drugs Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Platinum-based Anticancer Drugs
Figure 2. Global Platinum-based Anticancer Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Platinum-based Anticancer Drugs Market Share by Type: 2024 & 2031
Figure 4. Cisplatin Product Picture
Figure 5. Carboplatin Product Picture
Figure 6. Oxaliplatin Product Picture
Figure 7. Nedaplatin Product Picture
Figure 8. Others Product Picture
Figure 9. Global Platinum-based Anticancer Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Platinum-based Anticancer Drugs Market Share by Application: 2024 & 2031
Figure 11. Testicular Cancer
Figure 12. Osteosarcoma
Figure 13. Breast Cancer
Figure 14. Esophageal Cancer
Figure 15. NSCLC
Figure 16. Other
Figure 17. Global Platinum-based Anticancer Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Platinum-based Anticancer Drugs Market Size (2020-2031) & (US$ Million)
Figure 19. Global Platinum-based Anticancer Drugs Sales (2020-2031) & (MT)
Figure 20. Global Platinum-based Anticancer Drugs Average Price (US$/MT) & (2020-2031)
Figure 21. Platinum-based Anticancer Drugs Report Years Considered
Figure 22. Platinum-based Anticancer Drugs Sales Share by Manufacturers in 2024
Figure 23. Global Platinum-based Anticancer Drugs Revenue Share by Manufacturers in 2024
Figure 24. Global 5 and 10 Largest Platinum-based Anticancer Drugs Players: Market Share by Revenue in Platinum-based Anticancer Drugs in 2024
Figure 25. Platinum-based Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Global Platinum-based Anticancer Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 27. North America Platinum-based Anticancer Drugs Sales Market Share by Country (2020-2031)
Figure 28. North America Platinum-based Anticancer Drugs Revenue Market Share by Country (2020-2031)
Figure 29. United States Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Canada Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Europe Platinum-based Anticancer Drugs Sales Market Share by Country (2020-2031)
Figure 32. Europe Platinum-based Anticancer Drugs Revenue Market Share by Country (2020-2031)
Figure 33. Germany Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. France Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. U.K. Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Italy Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Russia Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Asia Pacific Platinum-based Anticancer Drugs Sales Market Share by Region (2020-2031)
Figure 39. Asia Pacific Platinum-based Anticancer Drugs Revenue Market Share by Region (2020-2031)
Figure 40. China Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Japan Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. South Korea Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. India Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Australia Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. China Taiwan Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Indonesia Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Thailand Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Malaysia Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Latin America Platinum-based Anticancer Drugs Sales Market Share by Country (2020-2031)
Figure 50. Latin America Platinum-based Anticancer Drugs Revenue Market Share by Country (2020-2031)
Figure 51. Mexico Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Brazil Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Argentina Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Middle East and Africa Platinum-based Anticancer Drugs Sales Market Share by Country (2020-2031)
Figure 55. Middle East and Africa Platinum-based Anticancer Drugs Revenue Market Share by Country (2020-2031)
Figure 56. Turkey Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Saudi Arabia Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. UAE Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Global Sales Market Share of Platinum-based Anticancer Drugs by Type (2020-2031)
Figure 60. Global Revenue Market Share of Platinum-based Anticancer Drugs by Type (2020-2031)
Figure 61. Global Platinum-based Anticancer Drugs Price (US$/MT) by Type (2020-2031)
Figure 62. Global Sales Market Share of Platinum-based Anticancer Drugs by Application (2020-2031)
Figure 63. Global Revenue Market Share of Platinum-based Anticancer Drugs by Application (2020-2031)
Figure 64. Global Platinum-based Anticancer Drugs Price (US$/MT) by Application (2020-2031)
Figure 65. Platinum-based Anticancer Drugs Value Chain
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Table 1. Global Platinum-based Anticancer Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Platinum-based Anticancer Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Platinum-based Anticancer Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Platinum-based Anticancer Drugs Sales (MT) of Key Manufacturers (2020-2025)
Table 5. Global Platinum-based Anticancer Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Platinum-based Anticancer Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Platinum-based Anticancer Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Platinum-based Anticancer Drugs Average Price (US$/MT) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Platinum-based Anticancer Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Platinum-based Anticancer Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Platinum-based Anticancer Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Platinum-based Anticancer Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Platinum-based Anticancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Platinum-based Anticancer Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Platinum-based Anticancer Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Platinum-based Anticancer Drugs Sales by Region (2020-2025) & (MT)
Table 18. Global Platinum-based Anticancer Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Platinum-based Anticancer Drugs Sales by Region (2026-2031) & (MT)
Table 20. Global Platinum-based Anticancer Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Platinum-based Anticancer Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Platinum-based Anticancer Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Platinum-based Anticancer Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Platinum-based Anticancer Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Platinum-based Anticancer Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Platinum-based Anticancer Drugs Sales by Country (2020-2025) & (MT)
Table 27. North America Platinum-based Anticancer Drugs Sales by Country (2026-2031) & (MT)
Table 28. North America Platinum-based Anticancer Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Platinum-based Anticancer Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Platinum-based Anticancer Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Platinum-based Anticancer Drugs Sales by Country (2020-2025) & (MT)
Table 32. Europe Platinum-based Anticancer Drugs Sales by Country (2026-2031) & (MT)
Table 33. Europe Platinum-based Anticancer Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Platinum-based Anticancer Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Platinum-based Anticancer Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Platinum-based Anticancer Drugs Sales by Region (2020-2025) & (MT)
Table 37. Asia Pacific Platinum-based Anticancer Drugs Sales by Region (2026-2031) & (MT)
Table 38. Asia Pacific Platinum-based Anticancer Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Platinum-based Anticancer Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Platinum-based Anticancer Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Platinum-based Anticancer Drugs Sales by Country (2020-2025) & (MT)
Table 42. Latin America Platinum-based Anticancer Drugs Sales by Country (2026-2031) & (MT)
Table 43. Latin America Platinum-based Anticancer Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Platinum-based Anticancer Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Platinum-based Anticancer Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Platinum-based Anticancer Drugs Sales by Country (2020-2025) & (MT)
Table 47. Middle East and Africa Platinum-based Anticancer Drugs Sales by Country (2026-2031) & (MT)
Table 48. Middle East and Africa Platinum-based Anticancer Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Platinum-based Anticancer Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Platinum-based Anticancer Drugs Sales (MT) by Type (2020-2025)
Table 51. Global Platinum-based Anticancer Drugs Sales (MT) by Type (2026-2031)
Table 52. Global Platinum-based Anticancer Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Platinum-based Anticancer Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Platinum-based Anticancer Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Platinum-based Anticancer Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Platinum-based Anticancer Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Platinum-based Anticancer Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Platinum-based Anticancer Drugs Price (US$/MT) by Type (2020-2025)
Table 59. Global Platinum-based Anticancer Drugs Price (US$/MT) by Type (2026-2031)
Table 60. Global Platinum-based Anticancer Drugs Sales (MT) by Application (2020-2025)
Table 61. Global Platinum-based Anticancer Drugs Sales (MT) by Application (2026-2031)
Table 62. Global Platinum-based Anticancer Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Platinum-based Anticancer Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Platinum-based Anticancer Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Platinum-based Anticancer Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Platinum-based Anticancer Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Platinum-based Anticancer Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Platinum-based Anticancer Drugs Price (US$/MT) by Application (2020-2025)
Table 69. Global Platinum-based Anticancer Drugs Price (US$/MT) by Application (2026-2031)
Table 70. Sanofi-Aventis Company Information
Table 71. Sanofi-Aventis Description and Business Overview
Table 72. Sanofi-Aventis Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 73. Sanofi-Aventis Platinum-based Anticancer Drugs Product
Table 74. Sanofi-Aventis Recent Developments/Updates
Table 75. Yakult honsha Company Information
Table 76. Yakult honsha Description and Business Overview
Table 77. Yakult honsha Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 78. Yakult honsha Platinum-based Anticancer Drugs Product
Table 79. Yakult honsha Recent Developments/Updates
Table 80. Dr Reddy's laboratories Company Information
Table 81. Dr Reddy's laboratories Description and Business Overview
Table 82. Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 83. Dr Reddy's laboratories Platinum-based Anticancer Drugs Product
Table 84. Dr Reddy's laboratories Recent Developments/Updates
Table 85. Sun Pharmaceutical Company Information
Table 86. Sun Pharmaceutical Description and Business Overview
Table 87. Sun Pharmaceutical Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 88. Sun Pharmaceutical Platinum-based Anticancer Drugs Product
Table 89. Sun Pharmaceutical Recent Developments/Updates
Table 90. Teva Company Information
Table 91. Teva Description and Business Overview
Table 92. Teva Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 93. Teva Platinum-based Anticancer Drugs Product
Table 94. Teva Recent Developments/Updates
Table 95. Fresenius Kabi Company Information
Table 96. Fresenius Kabi Description and Business Overview
Table 97. Fresenius Kabi Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 98. Fresenius Kabi Platinum-based Anticancer Drugs Product
Table 99. Fresenius Kabi Recent Developments/Updates
Table 100. Hospira(Pfizer) Company Information
Table 101. Hospira(Pfizer) Description and Business Overview
Table 102. Hospira(Pfizer) Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 103. Hospira(Pfizer) Platinum-based Anticancer Drugs Product
Table 104. Hospira(Pfizer) Recent Developments/Updates
Table 105. Mylan Company Information
Table 106. Mylan Description and Business Overview
Table 107. Mylan Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 108. Mylan Platinum-based Anticancer Drugs Product
Table 109. Mylan Recent Developments/Updates
Table 110. Taj Pharmaceuticals Company Information
Table 111. Taj Pharmaceuticals Description and Business Overview
Table 112. Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 113. Taj Pharmaceuticals Platinum-based Anticancer Drugs Product
Table 114. Taj Pharmaceuticals Recent Developments/Updates
Table 115. Jiangsu Hengrui Medicine Company Information
Table 116. Jiangsu Hengrui Medicine Description and Business Overview
Table 117. Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 118. Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Product
Table 119. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 120. Nanjing Pharmaceutical Factory Company Information
Table 121. Nanjing Pharmaceutical Factory Description and Business Overview
Table 122. Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 123. Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Product
Table 124. Nanjing Pharmaceutical Factory Recent Developments/Updates
Table 125. Jiangsu Aosaikang Pharmaceutical Company Information
Table 126. Jiangsu Aosaikang Pharmaceutical Description and Business Overview
Table 127. Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 128. Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Product
Table 129. Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
Table 130. Qilu Pharmaceutical Company Information
Table 131. Qilu Pharmaceutical Description and Business Overview
Table 132. Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 133. Qilu Pharmaceutical Platinum-based Anticancer Drugs Product
Table 134. Qilu Pharmaceutical Recent Developments/Updates
Table 135. Hisun Pharmaceutical Company Information
Table 136. Hisun Pharmaceutical Description and Business Overview
Table 137. Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 138. Hisun Pharmaceutical Platinum-based Anticancer Drugs Product
Table 139. Hisun Pharmaceutical Recent Developments/Updates
Table 140. Luoxin Company Information
Table 141. Luoxin Description and Business Overview
Table 142. Luoxin Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 143. Luoxin Platinum-based Anticancer Drugs Product
Table 144. Luoxin Recent Developments/Updates
Table 145. Lingnan Pharmacy Company Information
Table 146. Lingnan Pharmacy Description and Business Overview
Table 147. Lingnan Pharmacy Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 148. Lingnan Pharmacy Platinum-based Anticancer Drugs Product
Table 149. Lingnan Pharmacy Recent Developments/Updates
Table 150. Hansoh Pharma Company Information
Table 151. Hansoh Pharma Description and Business Overview
Table 152. Hansoh Pharma Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
Table 153. Hansoh Pharma Platinum-based Anticancer Drugs Product
Table 154. Hansoh Pharma Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Platinum-based Anticancer Drugs Distributors List
Table 158. Platinum-based Anticancer Drugs Customers List
Table 159. Platinum-based Anticancer Drugs Market Trends
Table 160. Platinum-based Anticancer Drugs Market Drivers
Table 161. Platinum-based Anticancer Drugs Market Challenges
Table 162. Platinum-based Anticancer Drugs Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Platinum-based Anticancer Drugs
Figure 2. Global Platinum-based Anticancer Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Platinum-based Anticancer Drugs Market Share by Type: 2024 & 2031
Figure 4. Cisplatin Product Picture
Figure 5. Carboplatin Product Picture
Figure 6. Oxaliplatin Product Picture
Figure 7. Nedaplatin Product Picture
Figure 8. Others Product Picture
Figure 9. Global Platinum-based Anticancer Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Platinum-based Anticancer Drugs Market Share by Application: 2024 & 2031
Figure 11. Testicular Cancer
Figure 12. Osteosarcoma
Figure 13. Breast Cancer
Figure 14. Esophageal Cancer
Figure 15. NSCLC
Figure 16. Other
Figure 17. Global Platinum-based Anticancer Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Platinum-based Anticancer Drugs Market Size (2020-2031) & (US$ Million)
Figure 19. Global Platinum-based Anticancer Drugs Sales (2020-2031) & (MT)
Figure 20. Global Platinum-based Anticancer Drugs Average Price (US$/MT) & (2020-2031)
Figure 21. Platinum-based Anticancer Drugs Report Years Considered
Figure 22. Platinum-based Anticancer Drugs Sales Share by Manufacturers in 2024
Figure 23. Global Platinum-based Anticancer Drugs Revenue Share by Manufacturers in 2024
Figure 24. Global 5 and 10 Largest Platinum-based Anticancer Drugs Players: Market Share by Revenue in Platinum-based Anticancer Drugs in 2024
Figure 25. Platinum-based Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Global Platinum-based Anticancer Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 27. North America Platinum-based Anticancer Drugs Sales Market Share by Country (2020-2031)
Figure 28. North America Platinum-based Anticancer Drugs Revenue Market Share by Country (2020-2031)
Figure 29. United States Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Canada Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Europe Platinum-based Anticancer Drugs Sales Market Share by Country (2020-2031)
Figure 32. Europe Platinum-based Anticancer Drugs Revenue Market Share by Country (2020-2031)
Figure 33. Germany Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. France Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. U.K. Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Italy Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Russia Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Asia Pacific Platinum-based Anticancer Drugs Sales Market Share by Region (2020-2031)
Figure 39. Asia Pacific Platinum-based Anticancer Drugs Revenue Market Share by Region (2020-2031)
Figure 40. China Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Japan Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. South Korea Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. India Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Australia Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. China Taiwan Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Indonesia Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Thailand Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Malaysia Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Latin America Platinum-based Anticancer Drugs Sales Market Share by Country (2020-2031)
Figure 50. Latin America Platinum-based Anticancer Drugs Revenue Market Share by Country (2020-2031)
Figure 51. Mexico Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Brazil Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Argentina Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Middle East and Africa Platinum-based Anticancer Drugs Sales Market Share by Country (2020-2031)
Figure 55. Middle East and Africa Platinum-based Anticancer Drugs Revenue Market Share by Country (2020-2031)
Figure 56. Turkey Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Saudi Arabia Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. UAE Platinum-based Anticancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Global Sales Market Share of Platinum-based Anticancer Drugs by Type (2020-2031)
Figure 60. Global Revenue Market Share of Platinum-based Anticancer Drugs by Type (2020-2031)
Figure 61. Global Platinum-based Anticancer Drugs Price (US$/MT) by Type (2020-2031)
Figure 62. Global Sales Market Share of Platinum-based Anticancer Drugs by Application (2020-2031)
Figure 63. Global Revenue Market Share of Platinum-based Anticancer Drugs by Application (2020-2031)
Figure 64. Global Platinum-based Anticancer Drugs Price (US$/MT) by Application (2020-2031)
Figure 65. Platinum-based Anticancer Drugs Value Chain
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Fatigue Analysis Engineering Services Market Research Report 2025
Jul 29, 25
Global Blast Impact Analysis Engineering Services Market Research Report 2025
Jul 29, 25
Global On-Line Analytical Processing (OLAP) Business Intelligence Consulting Services Market Research Report 2025
Jul 29, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232